Ligand-based drug design (LBDD)Vivek YadavJurnal ReangVinitaRajiv Kumar TonkComputer Aided Drug Design (CADD): From Ligand-Based Methods to Structure-Based Approaches
In a lot of cases, ligand-based drug design and structure-based drug design can be applied together to develop potent drug candidates. These methods have been applied in different stages and aspects in the research and development at HitGen and benefitted multiple projects....
1) Ligand-based drug design 基于配体的药物设计2) substrate based design 基于底物的药物设计 1. In recent years, three methods of molecular design have been developed, including substrate based design,structure based design and combinatorial chemistry technology. 近年来 ,科学家们发展了三种分子设计...
Yu et al., "Structure-based and ligand-based drug design for HER 2 receptor," Journal of Biomolecular Structure & Dynamics, vol. 28, no. 1, pp. 23-37, 2010.H.-J. Huang, K.-J. Lee, H. W. Yu et al., "Structure-based and ligand-based drug design for HER 2 receptor," ...
Ligand Based Drug Design (LBDD) models have been also applied to CK2 drug discovery, however they were mainly focused on methodology improvements rather ... G Cozza - 《Pharmaceuticals》 被引量: 11发表: 2017年 加载更多 来源期刊 Current Drug Discovery Technologies 研究点推荐 Ligand-based drug ...
The BioPharmics platform's cutting edge ligand- and structure-based drug design methods, enable fast, accurate & robust 3D modelling.
Fragment-based drug design consists of identifying low-molecular weight compounds that weakly bind to a target macromolecule and will then be modified or linked to yield potent inhibitors. The specificity of these low-complexity and low-affinity molecules has rarely been discussed in the literature. ...
drug design- structure and ligand-based appraoches. (kenneth merz etl.) 药学 药物化学 第13页 小木虫 论坛
State-of-the-art, structure-based method for assessing the energetics of water solvating ligand binding sites for ligand optimization Life Science Phase An easy-to-use pharmacophore modeling solution for ligand- and structure-based drug design Life Science Prime A powerful and innovative solution...
structure-based drug design SBVS: structure-based virtual screening References Schöneberg, T., and Liebscher, I. (2021) Mutations in G protein-coupled receptors: mechanisms, pathophysiology and potential therapeutic approaches, Pharmacol. Rev., 73, 89-119, https://doi.org/10.1124/pharmrev.12...